The objectives of this article are to review the diagnosis and management of acute nonrenal reactions to iodinated contrast media. We will begin by discussing the types of contrast media and their correlative rates of reaction. The mechanism of contrast reactions, predisposing risk factors, and preventative measures will then be discussed. The remainder of the article will review the assessment of potential reactions, initial management, and treatment algorithms for specific reactions.
Acute contrast reactions may present with a wide spectrum of symptoms and can affect multiple organ systems. Severe reactions may progress to life-threatening emergencies if not managed appropriately and efficiently. It is imperative that radiologists and medical personnel who administer intravascular contrast are aware of these implications and are prepared to diagnose and treat acute reactions. In this article, we discuss the diagnosis and management of acute nonrenal iodinated contrast reactions. We also review the incidence, pathogenesis, risk factors, and prevention of such reactions.
High-Osmolar vs Low-Osmolar Contrast Media
The osmolality of a particular contrast agent is determined by the number of osmotically active particles formed when it dissolves in solution. Ionic high-osmolal contrast media (HOCM) agents are ionic salts that dissociate into a cation and anion in solution [1, 2] . Nonionic low-osmolal contrast media (LOCM) agents do not dissociate into separate particles. Therefore, LOCMs have approximately one-half of the osmolality of HOCMs [2] . The hyperosmolality of contrast agents is believed to be at least partly responsible for several subjective and objective adverse effects, including pain, endothelial damage, thrombosis, and bradycardia [3, 4] .
The overall incidence of adverse contrast reactions is significantly lower for nonionic LOCM agents than HOCM [5e7]. The European Society of Urogenital Radiology reports that mild adverse reactions are encountered in as many as 15% of patients after intravenous HOCM (1000-2000 mOsm/kg H 2 O), compared with 3% of patients after intravenous LOCM (500-1000 mOsm/kg H 2 O) [5e7]. In 1990, Katayama et al [8] performed a large-scale (337,647 cases) prospective clinical study that compared the incidence of adverse contrast reactions in ionic HOCM vs nonionic LOCM. The overall prevalence of adverse reactions was 12.66% in the HOCM group and 3.13% in the LOCM group. Severe reactions occurred in 0.22% in the former group compared with 0.04% in the latter group [8] . Thus, the incidence of contrast reactions with LOCM is lower by a factor of 5 for mild reactions and by a factor of 10 for severe reactions, compared with HOCM [6, 9] .
The rate of fatal reactions to contrast media has decreased significantly over time. According to the study by Katayama et al [8] , the risk of a fatal reaction after injection of LOCM is approximately 1 in 170,000 as of 1990. The reduction of fatal reactions from 1 in 30,000 to 1 in 170,000 over the preceding 30 years has been attributed to both increasing use of LOCMs as well as improved training among radiologists and personnel to diagnose and treat acute events [10] .
Mechanism of Contrast Reaction
The exact pathogenesis for contrast-induced anaphylactoid reactions is still unknown, but several theories have been reported. Elliot Lasser has proposed that the contrast-containing molecule does not bind directly to an antigen-specific site [11] . Instead, the large molecule overloads antigen-binding sites on immunoglobulin E proteins situated on basophils and mast cells. Because this immunoglobulin binding is nonspecific, the resultant contrast reaction depends on the quantity of circulating immunoglobulin E and mast cells at the time of contrast administration. This binding also varies with the type of contrast media administered. This theory of nonspecific immunoglobulin binding on inflammatory cells may explain why patients with a strong allergy history are more prone to contrast reactions and why prior contrast exposure is not a requisite for a severe anaphylactoid reaction to occur [10, 11] .
Activation of factor XII (Hageman factor) of the clotting system, with subsequent activation of the kinin system and production of bradykinin, may also contribute to the pathomechanism for anaphylactoid contrast reactions. Bradykinin may cause vasodilation, bronchospasm, and increased vascular permeability [12e15] . Bradykinin may also activate the cyclooxygenase and lipoxygenase inflammatory pathways and the production of prostaglandin and leukotrienes [10, 12] . Patients with asthma or allergy have increased levels of factor XII products, which likely renders them more susceptible to adverse contrast reactions [14, 15] .
Predisposing Risk Factors
The predisposing risk factors are shown in Table 1 . The strongest risk factors for acute adverse contrast reactions are history of severe reaction and asthma. There is a 6-fold increase in adverse reactions to both ionic and nonionic contrast media in patients with a history of severe adverse reaction [12] . Recurrent adverse reaction occurs in 17%-35% of patients with a history of adverse reaction when HOCM agents are used; use of LOCM agents reduces this risk of recurrent reaction to 5% [16] . Asthma increases the risk of adverse reactions by 10-fold when HOCMs are used and by 6-fold when LOCMs are used [12, 16] .
Patients who are debilitated or medically unstable are inherently at increased risk for an adverse reaction due to the chemotoxic effects of intravascular contrast media [17] . Patients with generalized allergic tendencies or diatheses, including troublesome hay fever, are also at increased risk for acute reactions [12, 17] . Patients on b-adrenergic blockers and interleukin 2 are more susceptible to contrast reactions [18e20]. Malignant tumours may also increase the incidence of anaphylactoid reactions, possibly due to increased histamine release in patients with tumour [12, 21] .
Prevention
If contrast must be administered, then the best treatment for acute reactions is prevention ( Table 2 ). If the patient has previously had a severe adverse reaction to intravascular contrast, then the necessity for contrast in the upcoming examination should be scrutinized by the radiologist. Noncontrast examinations may suffice in many cases. If iodinated contrast is deemed essential, then nonionic LOCM should be administered.
Several researchers have demonstrated that premedication with corticosteroids reduces the incidence of adverse reactions to intravascular contrast media. In a 1987 randomized controlled trial by Lasser et al [22] , 2 doses of oral corticosteroids (32 mg methylprednisolone) 12 hours and 2 hours before ionic contrast administration reduced the risk of all adverse reactions from 9% to 6.4%. The frequency of severe reactions was also reduced from 2% to 1.2% [22] . In 1984, Greenberger et al [23] showed that a premedication regimen of 50 mg of oral prednisolone at 13 hours, 7 hours, and 1 hour before injection of the contrast material and 50 mg of oral diphenhydramine at 1 hour before ionic contrast media injection reduced the rate of adverse reactions from 9% to 7% in those patients with previous reactions. Antihistamines are often incorporated into premedication regimens because of their generalized anti-inflammatory effects. Results of studies Table 2 Recommended premedication protocols for patients at high-risk for acute contrast reactions a Lasser protocol: 32 mg oral methylprednisolone 12 h and 2 h before examination. Greenberger protocol: 50 mg oral prednisone 13 h, 7 h, and 1 h before examination; 50 mg oral diphenhydramine 1 h before examination. a From Ref. have not shown, however, antihistamines alone, without corticosteroids, have not been proven to effectively prevent adverse reactions [24] .
Types of Contrast Reactions
Types of contrast reactions are shown in Table 3 . Acute reactions to contrast media are defined as adverse events that occur within 60 minutes of injection of contrast media [5] . Reactions may be categorized as mild, moderate, or severe. Mild reactions include flushing, nausea, vomiting, pruritus, headache, and mild urticaria. These reaction are usually brief in duration and self-limiting and require no specific treatment. Moderate reactions include bronchospasm, moderate urticaria, and vasovagal reactions. These conditions respond readily to appropriate treatment. Severe reactions include laryngeal oedema, severe bronchospasm, seizure, and cardiovascular collapse. These entities are life-threatening and require rapid intervention [5, 17, 25] .
The majority of adverse reactions to intravascular contrast agents are mild. A 2009 study by Hunt et al [25] retrospectively reviewed 456,930 contrast doses (298,491 lowosmolar iodinated, 158,439 gadolinium) administered over the 4-year study period. They reported that the most common adverse effects were hives (275 [52.5% of all adverse effects]) and nausea (92 [17.6%]). These reactions were typically managed either with observation or diphenhydramine [25] .
It has been reported that 94%-100 % of severe and fatal reactions to intravascular contrast media occur within 20 minutes after contrast administration [26, 27] . For this reason, the European Society of Urogenital Radiology recommends that patients be observed for 20-30 minutes in the radiology department after contrast medium injection [27] .
Basics for Initial Assessment and Management
Bush and Segal [10] assert that, when a contrast reaction is recognized and managed earlier, less medication is required to achieve a better outcome. The goals of the treating radiologist and assisting personnel should include prompt recognition of a possible reaction, early patient assessment, diagnosis of reaction type, and rapid initiation of appropriate therapy. In areas where intravascular contrast is administered, first-line therapy and equipment should be stocked and accessible at all times. Recommended medications and equipment that should be available in such areas are listed in Table 4 .
Basic management principles for contrast reactions include the following [ The ABCs of acute cardiopulmonary resuscitation, assessment of airway, breathing, circulation, are of paramount importance when managing contrast reactions. After the appropriate emergency response team has been called, ensuring or establishing an airway and ventilating the patient must be performed. Basic methods to ensure airway patency include the head tilt-chin lift maneuver, suctioning, and an oropharyngeal airway. Advanced airway adjuncts include a laryngeal mask airway and endotracheal intubation [28] . Supplemental oxygen should be administered by mask at a high rate (6-10 L/min). Hypoxia may complicate virtually all emergencies that occur in a radiology department, contrast or noncontrast related (eg, cardiac ischemia, vasovagal event, seizure). Oxygen should be used for all patients with moderate or severe reactions. Administration via nasal prongs is much less effective than with a mask and should be avoided if possible [5] . A history of chronic obstructive pulmonary disease or emphysema is not a contraindication for oxygen therapy in contrast reactions. In acute settings, prevention of tissue hypoxia supersedes carbon dioxide retention concerns in this patient group [29] .
Once airway and ventilation have been managed, attention is then turned to the patient's circulatory system. Obtaining intravenous access with at least 2 large-bore IVs and initiating fluid resuscitation is critical for contrast-related hypotension. Intravascular fluid resuscitation alone has been reported to be the most effective treatment for hypotension [30] . Elevating the patient's legs 45 or more is a useful adjunct, because this maneuver may increase central venous return by up to 700 mL [31] . Mild reactions comprise the vast majority of acute contrast reactions. If, upon the initial assessment, the patient has stable vital signs with a secure airway, then the radiologist may perform more detailed respiratory and skin evaluations [1, 5, 10, 17] . Talking with the patient will assess whether he or she is short of breath or experiencing hoarseness, or has excessive coughing [5, 10] . Auscultation of the neck and chest may reveal inspiratory stridor worrisome for laryngeal oedema, expiratory wheezing consistent with bronchospasm, or rales and/or crackles suggestive of pulmonary oedema. Skin may be evaluated for hives, erythema, or oedema.
The patient's overall demeanor may be helpful in narrowing the differential diagnosis of adverse reactions. For example, the uncomfortable but calm patient may have a cutaneous reaction, with itching and hives. Observation alone or diphenhydramine for symptomatic relief may be all that is needed. The subdued or poorly responsive patient is likely experiencing cardiovascular compromise, either in the form of a vasovagal reaction or primary hypotension and diffuse systemic vasodilation. The patient who is anxious or agitated is likely experiencing respiratory compromise. Laryngeal oedema and bronchospasm are of primary concern for this patient group. Other, less likely, etiologies include pulmonary oedema, hypertensive crisis, and anxiety reaction [1, 10] .
Special Considerations in Pediatric Patients
The incidence of adverse contrast reactions in children is rare and increases in frequency with advancing age. In a large retrospective study by Callahan et al [32] performed at an urban children's hospital, the incidence of adverse reaction to nonionic contrast media was 0.46% (57 of 12,4949 patients). The majority of these reactions (47 of 57) were mild [32] . The most common reactions in pediatric patients are cutaneous and respiratory in nature. Pediatric patients increased susceptibility to respiratory reactions may be due to small airway calibre and/or immature respiratory musculature [1, 6] . Reactions can be harder to detect in children due to the inability to communicate symptoms. Management of pediatric contrast reactions is similar to management in adults but with age-appropriate medication dosage ( Table 6 ) [33] .
Treatment of Specific Acute Contrast Reactions
The following section describes treatment guidelines for specific reactions. These guidelines are summarized in Table 5 . Pediatric dosage modifications are listed in Table 6 .
Nausea and Vomiting
Nausea and/or vomiting after contrast administration are typically self-limited. It is recommended to keep these patients under close observation for at least 30 minutes while maintaining intravenous access [5] . Decubitus positioning in Table 5 Recognition the recumbent patient is recommended to minimize the risk of aspiration. In refractory cases, antiemesis medications may be administered intravenously [1, 5] .
Urticaria
Patients who experience urticaria are typically calm but uncomfortable [6] . These responses are limited to the skin and soft tissues. Local vasodilation causes erythema, and capillary leakage causes the red raised skin wheal that is characteristic of urticaria. Pruritus is the most common symptom [1] . If urticaria manifests only as a few scattered hives or mild pruritus, then treatment is generally not necessary. If the cutaneous response is protracted, more extensive in distribution, or particularly bothersome to the patient, then therapy may be initiated. An H1 antihistamine such as diphenhydramine (Benadryl; McNeil Consumer Healthcare, Fort Washington, PA), 25-50 mg orally or 25 mg intravenously in adult patients, often suffices [17] .
Vasovagal Reaction
The subdued or poorly responsive patient should be suspected of having contrast-related hypotension [10] . Sinus bradycardia (pulse rate less than 60 beats per minute) and hypotension (systolic blood pressure less than 80 mm Hg) in the acute setting are classic manifestations of a vasovagal reaction. Loss of consciousness may or may not occur. The pathophysiology for this entity involves a parasympathetic reflex activation that triggers a rapid decrease in heartbeat and reduction in vascular tone [34] .
Although it was previously believed to be the result of cardiac mechanoreceptors, cerebral signal is now considered more probable [35] .
Initial management for vasovagal reactions includes leg elevation, intravenous fluid resuscitation, and oxygen by mask. If the symptomatic bradycardia persists, then intravenous atropine may be administered. Atropine inhibits vagal stimulation on the heart, which results in increased chronotropy [36] . In the adult patient, 0.6-1.0 mg should be administered intravenously, repeating if necessary after 3-5 minutes, to a maximum dose of 3 mg. In pediatric patients, 0.02 mg/kg should be administered intravenously (maximum of 0.6 mg per dose), repeating as necessary after 3-5 minutes to a maximum dose of 2 mg [5] .
Isolated Hypotension
Profound hypotension without respiratory symptoms may result after intravascular contrast administration. Either normal sinus rhythm or compensatory tachycardia may occur, in contradistinction to the bradycardia seen in vasovagal reactions. Leg elevation and rapid intravenous fluid resuscitation are critical for increasing central venous return [30, 31] . High-rate supplemental oxygen is also recommended. If hypotension is recalcitrant to initial management, then intravenous or intramuscular epinephrine is warranted to facilitate vasoconstriction [37] .
Bronchospasm
The hallmark of bronchospasm is expiratory wheezing on chest auscultation, as in asthma. Bronchospasm without cardiovascular findings is best treated with supplemental oxygen and bronchodilator therapy. A b-2 agonist, such as albuterol, may be administered via a metered-dose inhaler; 2-3 deep inhalations are typically performed [38] . For moderate or severe bronchospasm that is refractory to bronchodilator therapy, epinephrine may be used for its generalized b-adrenergic stimulation [10] .
Laryngeal Oedema
This reaction involves angioedema of the upper aerodigestive tract. Common presenting symptoms include newonset voice changes or hoarseness, cough, sensation of a lump or tightness within the throat, and inspiratory stridor. These patients are often anxious or agitated. Severe laryngeal oedema may progress towards fatal airway obstruction, which necessitates rapid diagnosis and therapy [39] . This condition does not respond well to bronchodilator therapy, and, in fact, b-agonists may worsen the angioedema [1] . Intubation may be difficult in these patients, which underscores the need for rapid epinephrine administration. Please refer to section ''Generalized Anaphylactoid Reactions'' for route and dosage guidelines.
Generalized Anaphylactoid Reactions
These entities are rapidly progressive systemic reactions characterized by multiorgan involvement. Possible manifestations include angioedema, respiratory distress, pulmonary oedema, hypotensive shock, and cardiac arrest [40] . When a severe anaphylactoid reaction is suspected, it is critical to get trained providers involved as early as possible. The radiologist should have a low threshold to call for assistance such as the rapid response team, emergency department, or intensive care unit.
Airway management, oxygen by mask, leg elevation, and intravenous fluids should be initiated immediately. Epinephrine is the mainstay of therapy for generalized anaphylactoid reactions. Epinephrine stimulates both aand b-adrenergic receptors [41] . With subcutaneous release, intramuscular, or slow intravenous injection, the desirable b-adrenergic effects predominate. Central b-agonist effects augment both the strength and rate of cardiac contractions, while peripherally there is bronchiolar relaxation [42] .
Intravenous epinephrine therapy is often warranted for severe anaphylactoid reactions: Epinephrine 0.1 mg (1 mL) of 1:10,000 concentration, given slowly over 2-5 minutes in adult patients; 0.01 mg/kg up to 0.1 mg per single dose of 1:10,000 concentration epinephrine in pediatric patients [1] . If only 1:1000 epinephrine is available, either dilution in normal saline solution should be performed or one-tenth the above volume should be administered. Dosing may be repeated as needed. It should be stressed that the intravenous route puts the patient at greater risk for harmful cardiovascular adverse effects, and is best used by experienced providers [43] .
Intramuscular administration of epinephrine is a viable alternative to the intravenous route. Autoinjector intramuscular devices such as EpiPen and EpiPen Jr (Dey Pharma, LP, Basking Ridge, NJ) deliver 0.3 mg and 0.15 mg to adult patients and to pediatric patients, respectively. Epinephrine autoinjectors have been increasingly used at many institutions because they provide an easy-to-use, sterile, premeasured single dose. The middle third of the thigh, usually the anterolateral aspect, is the recommended administration site due to easy accessibility and sufficient muscle bulk in this location. Dosing may be repeated after 5 minutes if the patient's symptoms do not resolve [43e45].
Patients who have experienced a severe anaphylactoid reaction should remain under close clinical observation for at least 6 hours after treatment [43, 46] . The incidence of biphasic reactions ranges from 1%-20% in the literature [47] . Patients at greater risk for these recurrent reactions include those with severe asthma, limited access to emergency health facilities, and the possibility of continued allergen absorption. In these high-risk patients, close observation for up to 24 hours may be warranted [43, 47] .
The reader is directed to the American College of Radiology Manual on Contrast Media, 7th edition, a Web-based document published in 2010, which serves as an excellent reference for all practicing radiologists regarding the safe use of contrast media [48] .
Conclusion
The incidence of acute reactions to intravascular contrast media fortunately is low. Low-osmolar iodinated agents are generally well tolerated and preferred to high-osmolar agents. The patients at highest risk for reaction include those with prior reactions and those with asthma. Avoidance of contrast media is the best form of prevention. For those patients who need contrast but are at increased risk of reaction, corticosteroid premedication regimens should be applied. Initial evaluation includes calling for help, assessing the patient, and taking vital signs, ensuring or establishing an airway, ventilating with supplemental oxygen, and circulatory support. For the most-severe anaphylactoid reactions, epinephrine is the medication of choice. Intramuscular and intravenous administration are the preferred routes. Prompt recognition of acute contrast reactions will facilitate treatment and improve patient outcomes.
